Spots Global Cancer Trial Database for Sphenopalatine Ganglion Block for the Treatment of Post-Stroke Headache
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Sphenopalatine Ganglion Block for the Treatment of Post-Stroke Headache
Official Title: Sphenopalatine Ganglion Block for the Treatment of Post-Stroke Headache
Study ID: NCT05365880
Study Description
Brief Summary: Determine the effects of sphenopalatine ganglion (SPG) block in post-stroke headache.
Detailed Description: The purpose of this study is to determine if sphenopalatine ganglion (SPG) block is a safe and effective treatment for acute post-stroke headache. Current literature lacks randomized controlled studies regarding the efficacy of different treatment modalities for acute post-stroke headache; additionally, there are no evidence-based guidelines for the treatment of acute post-stroke headache. Sphenopalatine ganglion block is a non-invasive procedure where an anesthetic agent is injected into the nares, reaching the SPG to relieve pain and autonomic features. This treatment has been effective in a variety of headache types but to our knowledge has not been studied in acute post-stroke headache.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Utah, Salt Lake City, Utah, United States
Contact Details
Name: Adam H de Havenon, MD
Affiliation: University of Utah
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
